Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?"

Abstract

In response to our article,1 Zhou and Zhao pose the question of whether interventions for prevention-of-mother-to-child-transmission (PMTCT) need to be enhanced. 2 As MTCT is now the major contributor to new cases of HBV infection, and approaching one million people die of this infection each year, the answer to this question is unequivocally yes – and with urgency. We tackle specific points raised by Zhou and Zhao in turn.